Dr. Jay Allen Lugthart , MD
General Practice • Jenison, MI
670 Baldwin St
Jenison, MI 494289757
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
NPI assigned on April 3, 2007; this date does not establish years in practice.
-
Published CMS data list 17 Original Medicare Part B services in 2023.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2023. Published rows only; this is not a quality measure.
-
Published Part B service records, 2023:
- 99214 — Established patient outpatient office visit: 17 service units.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2023. Units differ by code; these are not visits or a measure of quality.
CPT® only copyright 2022 American Medical Association. All rights reserved. Service names are shortened from CPT Consumer Friendly Descriptors (CMS data, 2023). CPT notice
See the full table · Guide: How to read Medicare Part B data
-
Published CMS data list 1,062 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Atorvastatin Calcium — 119 prescription fills, including refills.
- Amlodipine Besylate — 89 prescription fills, including refills.
- Metoprolol Succinate — 81 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 30 records in the table · Guide: How to read Medicare Part D prescriber data
-
Close to the middle for Part D prescriptions among clinicians listed under General Practice in Michigan (2024, 108 clinicians with data). Median for this group: 595. Middle half: 93 to 2,631.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part B services went from 357 in 2019 to 17 in 2023.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2019–2023.
Practice Location & Contact Primary Location
670 Baldwin St
Jenison, MI 494289757
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
What Public CMS Data Show
General Practice: NPPES taxonomy is a reported classification, not proof of board certification.
Medicare-allowed amount
About $2,072 in 2023
The total amount Medicare approved for these services in 2023. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.
It shows the total cost of this clinician's Original Medicare services under Medicare's fee rules.
What this does not show: Medicare-allowed amount
This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2023.
Paid by Medicare
About $1,391 in 2023
The part of the Medicare-allowed amount that Medicare itself paid in 2023, after patients' deductibles and coinsurance.
The gap between the allowed amount and this number is roughly what patients and their other insurance paid.
What this does not show: Paid by Medicare
This is not the clinician's income and not a measure of quality.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2023.
30-day fills
2,813 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$133,197 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.
Open Payments general payments, program year 2023
All general payments: $936.81 across 31 records.
By nature of payment
- Food and Beverage: $936.81 across 31 records.
Reporting-company totals (3 largest of 12)
- AstraZeneca Pharmaceuticals LP: $447.43 across 7 records.
- Novo Nordisk Inc: $177.51 across 6 records.
- Amgen Inc.: $68.85 across 4 records.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2023 (published June 30, 2026).
NPI first issued
2007
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Medicare assignment not listed
CMS data do not show whether this clinician accepts Medicare assignment. This does not mean they do not accept Medicare. Ask the office.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians; Medicare.gov, “Does your provider accept Medicare as full payment?”
No telehealth indicator
CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.
Compared with the same specialty in Jenison and Michigan
Billing and prescribing volume is not a quality rating.
Medicare Part D prescriptions
Close to the middle for clinicians listed under General Practice in Michigan (2024, 108 clinicians with data). Median for this group: 595. Middle half: 93 to 2,631.
Too few clinicians listed under General Practice in Jenison have Medicare Part D data for 2024 to compare.
Part D drug cost
A higher Part D drug cost than 65% of clinicians listed under General Practice in Michigan (2024, 108 clinicians with data). Median for this group: $21,383. Middle half: $1,014 to $243,259.
Too few clinicians listed under General Practice in Jenison have Medicare Part D data for 2024 to compare.
Medicare Part B
Comparisons use 2024 data. The latest CMS data for Dr. Lugthart are from 2023.
1 active clinicians are listed under General Practice with a practice address in Jenison, MI (369 in Michigan).
Addresses are self-reported to NPPES and may be out of date.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part B services
Medicare Part B services decreased 95% from 357 in 2019 to 17 in 2023.
- 2019: 357
- 2020: 235
- 2021: 198
- 2022: 171
- 2023: 17
-
Medicare-allowed amount
Medicare-allowed amount decreased 92% from $27,063 in 2019 to $2,072 in 2023.
- 2019: $27,063
- 2020: $18,718
- 2021: $21,099
- 2022: $19,357
- 2023: $2,072
-
Paid by Medicare
Paid by Medicare decreased 92% from $16,986 in 2019 to $1,391 in 2023.
- 2019: $16,986
- 2020: $11,553
- 2021: $13,040
- 2022: $12,601
- 2023: $1,391
-
Medicare Part D prescriptions
Medicare Part D prescriptions decreased 85% from 7,239 in 2020 to 1,062 in 2024.
- 2020: 7,239
- 2021: 7,881
- 2022: 7,931
- 2023: 7,071
- 2024: 1,062
-
30-day fills
30-day fills decreased 82% from 16,042 in 2020 to 2,813 in 2024.
- 2020: 16,042
- 2021: 17,721
- 2022: 17,281
- 2023: 15,857
- 2024: 2,813
-
Part D drug cost
Part D drug cost decreased 78% from $593,303 in 2020 to $133,197 in 2024.
- 2020: $593,303
- 2021: $675,159
- 2022: $834,743
- 2023: $793,054
- 2024: $133,197
-
Industry payments (Open Payments)
Industry payments (Open Payments) decreased 59% from $2,298.21 in 2019 to $936.81 in 2023.
- 2019: $2,298.21
- 2020: $700.22
- 2021: $1,358.11
- 2022: $1,729.16
- 2023: $936.81
Sources: CMS Medicare Physician & Other Practitioners (2023), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2023), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo · Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2023 (payments made January 1 – December 31, 2023): 31 records totaling $936.81.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
BREZTRI | General | $167.83 |
| Novo Nordisk Inc |
Food and Beverage
In-kind items and services
|
Wegovy | General | $124.99 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
FARXIGA | General | $101.95 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
FARXIGA | General | $87.68 |
| Bayer Healthcare Pharmaceuticals Inc. |
Food and Beverage
In-kind items and services
|
Kerendia | General | $28.61 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
BREZTRI | General | $25.00 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
FARXIGA | General | $23.38 |
| GlaxoSmithKline, LLC. |
Food and Beverage
In-kind items and services
|
TRELEGY ELLIPTA | General | $23.38 |
| Xeris Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
GVOKE HYPOPEN | General | $21.39 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
FARXIGA | General | $21.20 |
| Amgen Inc. |
Food and Beverage
In-kind items and services
|
Otezla | General | $20.97 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
FARXIGA | General | $20.39 |
| Amgen Inc. |
Food and Beverage
In-kind items and services
|
Otezla | General | $19.07 |
| Eli Lilly and Company |
Food and Beverage
In-kind items and services
|
EMGALITY | General | $18.52 |
| Novo Nordisk Inc |
Food and Beverage
In-kind items and services
|
Wegovy | General | $17.62 |
| GlaxoSmithKline, LLC. |
Food and Beverage
In-kind items and services
|
TRELEGY ELLIPTA | General | $17.61 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
UBRELVY | General | $17.44 |
| Eli Lilly and Company |
Food and Beverage
In-kind items and services
|
MOUNJARO | General | $17.06 |
| Novo Nordisk Inc |
Food and Beverage
In-kind items and services
|
Wegovy | General | $16.16 |
| GlaxoSmithKline, LLC. |
Food and Beverage
In-kind items and services
|
TRELEGY ELLIPTA | General | $15.66 |
| Teva Pharmaceuticals USA, Inc. |
Food and Beverage
In-kind items and services
|
Austedo XR | General | $15.53 |
| Amgen Inc. |
Food and Beverage
In-kind items and services
|
EVENITY | General | $14.87 |
| Supernus Pharmaceuticals, Inc. |
Food and Beverage
Cash or cash equivalent
|
QELBREE | General | $14.70 |
| Amgen Inc. |
Food and Beverage
In-kind items and services
|
Otezla | General | $13.94 |
| Teva Pharmaceuticals USA, Inc. |
Food and Beverage
In-kind items and services
|
AJOVY | General | $13.72 |
(top 25 shown)
Source: CMS Open Payments, program year 2023, released June 30, 2026.
Performed Procedures & Service Volume
CPT® is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2016–2022 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners – by Provider and Service data, 2017–2023; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
| HCPCS Code | Services | Patients | Submitted Charge | Medicare Allowed |
|---|---|---|---|---|
|
99214
Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
|
17 | 14 | $168.00 | $121.91 |
Source: CMS Part B by Provider and Service, 2023; services under 11 beneficiaries omitted by CMS. Privacy limits
Submitted charges are billed amounts, not a price quote for your visit.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 119 | 9,540 | $2,483.74 | 69 |
| Amlodipine Besylate | Amlodipine Besylate | 89 | 6,870 | $919.21 | 50 |
| Metoprolol Succinate | Metoprolol Succinate | 81 | 6,840 | $2,248.61 | 44 |
| Omeprazole | Omeprazole | 78 | 6,450 | $1,736.23 | 48 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 76 | 6,840 | $1,662.91 | 49 |
| Losartan Potassium | Losartan Potassium | 62 | 5,580 | $1,417.20 | 37 |
| Lisinopril | Lisinopril | 59 | 4,950 | $940.08 | 39 |
| Hydrochlorothiazide | Hydrochlorothiazide | 55 | 4,650 | $280.23 | 34 |
| Levothyroxine Sodium | Levothyroxine Sodium | 45 | 3,990 | $985.88 | 31 |
| Tamsulosin Hcl | Tamsulosin Hcl | 31 | 2,250 | $667.17 | 20 |
| Meloxicam | Meloxicam | 26 | 1,800 | $196.44 | 17 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 26 | 990 | $20,243.72 | — |
| Metformin Hcl Er | Metformin Hcl | 24 | 2,160 | $382.66 | 14 |
| Farxiga | Dapagliflozin Propanediol | 24 | 1,800 | $30,791.19 | 11 |
| Fluticasone Propionate | Fluticasone Propionate | 21 | 1,470 | $355.61 | — |
| Ezetimibe | Ezetimibe | 21 | 1,350 | $747.51 | — |
| Simvastatin | Simvastatin | 20 | 1,740 | $319.61 | 13 |
| Metformin Hcl | Metformin Hcl | 19 | 1,710 | $445.52 | 12 |
| Pantoprazole Sodium | Pantoprazole Sodium | 19 | 1,230 | $269.42 | — |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 19 | 727 | $825.61 | — |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 17 | 1,350 | $256.37 | — |
| Eliquis | Apixaban | 17 | 1,530 | $26,698.20 | — |
| Duloxetine Hcl | Duloxetine Hcl | 17 | 1,290 | $694.71 | — |
| Xarelto | Rivaroxaban | 16 | 1,260 | $21,252.12 | — |
| Pravastatin Sodium | Pravastatin Sodium | 16 | 1,380 | $340.33 | — |
(top 25 shown)
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
NUCC Taxonomy Code: 208D00000X
A physician who specializes in the general practice of diagnosing, treating, and managing patients with a variety of illnesses and conditions.
NUCC Taxonomy Code: 207QG0300X
A family medicine physician with special knowledge of the aging process and special skills in the diagnostic, therapeutic, preventive and rehabilitative aspects of illness in the elderly. This specialist cares for geriatric patients in the patient's home, the office, long-term care settings such as nursing homes, and the hospital.
NUCC Taxonomy Code: 207PE0004X
An emergency medicine physician who specializes in non-hospital based emergency medical services (e.g., disaster site, accident scene, transport vehicle, etc.) to provide pre-hospital assessment, treatment, and transport patients.
Additional State Medicaid & Healthcare Payer Identifiers
Career & Practice History
NPI enumerated April 03, 2007.
No changes to the name, practice address, taxonomy or NPI status in this record have been observed in the monthly NPPES data files from January 2017 to August 2026.
NPI Administrative Meta
Mailing Address
4419 68th St Sw
Byron Center, MI 493159428